Information  X 
Enter a valid email address

Syncona Limited (SYNC)

  Print      Mail a friend

Friday 21 June, 2019

Syncona Limited

Director Information

RNS Number : 0899D
Syncona Limited
21 June 2019

Syncona Limited

Director Information


21 June 2019 

Syncona Limited announces that Nick Moss, a Non-Executive Director, has informed the Company that he has retired from the Board of BH Global Limited, a company listed on the London Stock Exchange, with effect from 21 June 2019.



Syncona Ltd

Annabel Clay / Siobhan Weaver

Tel: +44 (0) 20 3981 7940


Citco Fund Services (Guernsey) Limited

Company Secretary

Tel: +44 (0) 1481 758228


About Syncona:

Syncona is a leading FTSE250 healthcare company focused on founding, building and funding global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.

We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses. We take a long-term view, underpinned by a deep pool of capital, and are established leaders in gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.

Copies of this press release, a company results presentation, and other corporate information can be found on the company website at: 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t